title: How effective is the use of long-term anti-TNF for paediatric IBD? Clues from real-life surveillance cohorts.
authors.affiliation: Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
authors.forename: Chani
authors.initials: C
authors.lastname: Topf-Olivestone
authors.affiliation: Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
authors.forename: Dan
authors.initials: D
authors.lastname: Turner
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001685:Biological Factors / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D001685:Biological Factors; D014409:Tumor Necrosis Factor-alpha
keywords: Gastroenterology; Outcomes research